Company intelligence / Profile preview

Prophase Biostudios

Austin, Texas, United Statesx.com ↗

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Prophase Biostudios operates as a biohacker and biotech incubator space focused on early-stage research projects such as nightvision eye drops, plastic-eating Amazonian mushrooms, and genetically engineered yeast/algae for improved nutrition. No clinical results are reported; activities appear to be at the proof-of-concept or prototyping stage.

Therapeutic areas: OphthalmologyMetabolic DisordersOther
Modalities: Genetically engineered yeast and algae (Biologic)Nightvision eye drops (Small molecule or Device, inferred)Cultivated mushrooms for bioremediation (Microbial therapy, inferred)
Industry: Academic Hospital/University/Research

Partnerships

None publicly listed; company is described as an open-access incubator supporting consultants and contractors with scientific equipment access.

Beyond the preview

Go deeper on Prophase Biostudios.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prophase Biostudios.

Explore the full profile